ABBOTT LABORATORIES : Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 18, 2021, Phebe N. Novakovic informed the Board of Directors of her decision not to stand for re-election at the end of her current term expiring at the 2021 annual shareholders meeting in April.

Item 5.03    Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year.

On February 19, 2021, Abbott's Board of Directors amended the first sentence of Article III, Section 2 of Abbott's by-laws to provide that Abbott's Board of Directors shall consist of thirteen persons, effective April 23, 2021. Abbott's by-laws currently provide that the Board of Directors consists of fourteen persons.

Item 9.01    Financial Statements and Exhibits



  Exhibit No.                               Exhibit

    3.1         By-Laws of Abbott Laboratories, as amended and restated, effective
              April 23, 2021.

  104         Cover Page Interactive Data File (the cover page XBRL tags are
              embedded in the Inline XBRL document).

© Edgar Online, source Glimpses